Goldiam International Ltd, a manufacturer and exporter of diamonds and jewellery, has made available the audio recording of its Q3FY26 earnings conference call that was held on February 10, 2026. The call discussed the company's unaudited financial results for both the quarter and nine months ended December 31, 2025.

Conference Call Completion

The earnings call was successfully conducted as scheduled on February 10, 2026, at 4:00 p.m. IST, following the company's regulatory obligations under SEBI guidelines. The conference call provided insights into the company's financial performance and operational developments for the reporting period.

Management Participation

The conference call featured key members of Goldiam International's management team who provided commentary on the financial results and business operations:

• Mr. Anmol Bhansali - Managing Director
• Mr. Rashesh Bhansali - Executive Director

Audio Recording Access

Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has made the complete audio recording of the earnings call available on its official website. The recording can be accessed through the following weblink:

Audio Recording URL: https://www.goldiam.com/pdf/transcript/2025-2026/Audio_Recording_of_Earnings_Call-10-02-2026.mp3

Regulatory Compliance

The announcement was made in continuation of the company's earlier letter dated February 5, 2026, and in compliance with SEBI listing regulations. Company Secretary & Compliance Officer Pankaj Parkhiya signed the regulatory filing, ensuring adherence to disclosure requirements.

Company Information

Goldiam International Ltd operates as a manufacturer and exporter of diamonds and jewellery with CIN: L36912MH1986PLC041203. The company's registered office is located at Gems & Jewellery Complex, Santacruz Electronics Export Processing Zone, Andheri (East), Mumbai-400096.

Goldiam International Limited has successfully passed its quarterly monitoring review for the utilization of proceeds from its Rs. 202.05 crore Qualified Institutional Placement (QIP), according to a report issued by CARE Ratings Limited for the quarter ended December 31, 2025.

QIP Utilization Overview

The monitoring agency confirmed that all proceeds utilized during Q3FY26 were in accordance with disclosures made in the placement document. The company has maintained transparency in fund deployment while ensuring optimal returns on unutilized amounts.

Fund Deployment Progress

The primary objective of the QIP is funding expenditure towards setting up 63 new brand-exclusive stores across India, with a total allocation of Rs. 194.96 crore. During Q3FY26, the company made significant progress in this initiative.

Store Expansion Activities

The company has opened 13 new retail stores till January 07, 2026, and signed MoUs for 19 additional stores planned for the coming months, progressing toward its target of 63 stores.

Investment of Unutilized Proceeds

CARE Ratings noted that Rs. 183.97 crore of unutilized proceeds have been strategically invested across various instruments to generate returns while maintaining liquidity for future deployment.

Investment Portfolio Breakdown

Regulatory Compliance and Approvals

The monitoring report confirmed that the company has obtained all necessary government and statutory approvals related to the project objectives. Board resolution dated August 11, 2025, authorized the management to invest unutilized QIP proceeds in creditworthy instruments until required for deployment.

Risk Factors and Market Considerations

CATE Ratings highlighted that the company derived approximately 99% of its sales in FY25 from exports, with the US contributing more than 95% of revenue. The monitoring agency noted that potential imposition of additional import tariffs on India could impact the company's performance in coming quarters.

The report also mentioned that Rs. 29.43 crore of unutilized proceeds have been invested in non-convertible debentures with maturities extending beyond the timeline specified in the placement document, though the company clarified these are listed instruments that can be liquidated within 2-3 working days.

Implementation Timeline

According to the placement document, the company plans to deploy Rs. 85.19 crore by March 31, 2026, and Rs. 110.01 crore by March 31, 2027. As of December 31, 2025, Rs. 13.44 crore has been utilized against the first milestone, indicating steady progress toward the implementation schedule.

The monitoring report found no deviations from the stated objectives and confirmed that shareholder approval requirements were not applicable as no material deviations occurred during the quarter.

Source: Exclusive